Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/643
Title: | Is a third arterial conduit necessary? Comparison of the radial artery and saphenous vein in patients receiving bilateral internal thoracic arteries for triple vessel coronary disease. |
Epworth Authors: | Fuller, John Buxton, Brian |
Other Authors: | Shi, William Tatoulis, James Newcomb, Andrew Rosalion, Alexander |
Keywords: | Cardiac Services Cardiology Arterial Conduit Coronary Artery Bypass Grafting Coronary Revascularization Radial Artery Arterial Grafting Cardiac Surgery Surgery Coronary Artery Disease Ischaemic Heart Disease Lesions Adenoma Thoracic Artery Radial Artery Saphenous Vein Thoracic Surgery Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia |
Issue Date: | Jan-2016 |
Publisher: | Oxford Journals |
Citation: | Eur J Cardiothorac Surg. 2016 Jan 19. pii: ezv467. [Epub ahead of print] |
Abstract: | OBJECTIVES: The use of bilateral internal thoracic arteries (BITAs) is associated with improved long-term survival after coronary artery bypass grafting (CABG). However, it is unclear whether the addition of a radial artery (RA) in patients already receiving BITA confers any additional survival benefit over that of a saphenous vein (SV). As such, we reviewed our multicentre experience and compared both strategies. METHODS: From 1995 to 2010, 1497 patients underwent primary isolated CABG for three-vessel coronary disease using BITAs. An SV was used as a third conduit in 460 (31%) patients and an RA in 1037 (69%). A total of 1258 distal anastomoses were performed using RAs and these were to the diagonal territory in 169, the circumflex in 454 and the right coronary in 635. Survival data were obtained using the National Death Index and propensity-score matching was used for risk-adjustment. RESULTS: The overall cohort was young (mean age 61 ± 9 years). Patients receiving RAs were more likely to be younger, and were less likely to have experienced a prior myocardial infarction. At 30 days, mortality was similar (BITA + SV: 5, 1.1% vs BITA + RA: 9, 0.9%, P = 0.77). At 15 years, BITA + RA patients experienced improved unadjusted survival (BITA + SV: 67 ± 4.6% vs BITA + RA: 82 ± 3.2%, P < 0.0001). Multivariable Cox regression in the entire cohort also showed the BITA + RA group to be associated with better survival (HR 0.58, 95% CI 0.44-0.75, P < 0.001). After propensity-score matching of 262 patient-pairs, BITA + RA experienced similar 30-day mortality (BITA + SV: 3, 1.1% vs BITA + RA: 3, 1.1%, P > 0.99). However, at 15 years, BITA + RA patients experienced improved risk-adjusted survival (BITA + SV: 72 ± 6.0% vs BITA + RA: 82 ± 5.2%, P = 0.021). The RA was associated with better risk-adjusted survival for grafting of the right coronary and its branches (148 matched pairs; SV-RCA: 74 ± 7.8% vs RA-RCA: 86 ± 6.5%, P = 0.0046 at 15 years). CONCLUSIONS: The addition of an RA graft even in patients already receiving BITAs is associated with a survival benefit. In younger patients with a reasonable long-term life expectancy, surgeons should strive to achieve total arterial revascularization with BITAs and radial arteries. |
URI: | http://hdl.handle.net/11434/643 |
DOI: | 10.1093/ejcts/ezv467 |
PubMed URL: | http://www.ncbi.nlm.nih.gov/pubmed/26792919 |
ISSN: | 1873-734X |
Journal Title: | European Journal of Cardio-Thoracic Surgery |
Type: | Journal Article |
Affiliated Organisations: | Department of Cardiothoracic Surgery, St Vincent's Hospital, Melbourne, Australia. Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, Australia. Department of Surgery, University of Melbourne, Melbourne, Australia. Department of Cardiac Surgery, Austin Hospital, Melbourne, Australia. |
Type of Clinical Study or Trial: | Multicentre Studies |
Appears in Collections: | Cardiac Sciences UroRenal, Vascular |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.